19-49871884-A-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_001098633.4(AKT1S1):c.385T>A(p.Phe129Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000044 in 1,613,176 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098633.4 missense
Scores
Clinical Significance
Conservation
Publications
- ataxia - oculomotor apraxia type 4Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P, Laboratory for Molecular Medicine
- microcephaly, seizures, and developmental delayInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Charcot-Marie-Tooth disease type 2B2Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AKT1S1 | NM_001098633.4 | c.385T>A | p.Phe129Ile | missense_variant | Exon 3 of 5 | ENST00000344175.10 | NP_001092103.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152074Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000599 AC: 15AN: 250504 AF XY: 0.0000590 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461102Hom.: 0 Cov.: 35 AF XY: 0.0000440 AC XY: 32AN XY: 726930 show subpopulations
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152074Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74282 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.385T>A (p.F129I) alteration is located in exon 3 (coding exon 2) of the AKT1S1 gene. This alteration results from a T to A substitution at nucleotide position 385, causing the phenylalanine (F) at amino acid position 129 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at